Unrecognized Tax Benefits of Edwards Lifesciences Corp from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Edwards Lifesciences Corp quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Edwards Lifesciences Corp Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $767,400,000, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Edwards Lifesciences Corp Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $767,400,000 +$88,600,000 +13% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $746,900,000 +$90,400,000 +14% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $722,100,000 +$103,000,000 +17% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $700,100,000 +$91,300,000 +15% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $678,800,000 +$94,900,000 +16% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $656,500,000 +$113,600,000 +21% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $619,100,000 +$99,100,000 +19% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 $608,800,000 +$112,000,000 +23% 31 Mar 2024 10-Q 29 Apr 2024 2024 Q1
Q4 2023 $583,900,000 +$108,600,000 +23% 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q3 2023 $542,900,000 +$124,600,000 +30% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $520,000,000 +$121,500,000 +30% 30 Jun 2023 10-Q 28 Jul 2023 2023 Q2
Q1 2023 $496,800,000 +$116,900,000 +31% 31 Mar 2023 10-Q 28 Apr 2023 2023 Q1
Q4 2022 $475,300,000 +$116,900,000 +33% 31 Dec 2022 10-K 25 Feb 2026 2025 FY
Q3 2022 $418,300,000 +$77,500,000 +23% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $398,500,000 +$79,800,000 +25% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $379,900,000 +$79,400,000 +26% 31 Mar 2022 10-Q 28 Apr 2022 2022 Q1
Q4 2021 $358,400,000 +$76,600,000 +27% 31 Dec 2021 10-K 28 Feb 2025 2024 FY
Q3 2021 $340,800,000 +$90,300,000 +36% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $318,700,000 +$95,500,000 +43% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $300,500,000 +$88,600,000 +42% 31 Mar 2021 10-Q 28 Apr 2021 2021 Q1
Q4 2020 $281,800,000 +$78,700,000 +39% 31 Dec 2020 10-K 12 Feb 2024 2023 FY
Q3 2020 $250,500,000 +$64,300,000 +35% 30 Sep 2020 10-Q 26 Oct 2020 2020 Q3
Q2 2020 $223,200,000 +$50,300,000 +29% 30 Jun 2020 10-Q 27 Jul 2020 2020 Q2
Q1 2020 $211,900,000 +$8,800,000 +4.3% 31 Mar 2020 10-Q 28 Apr 2020 2020 Q1
Q4 2019 $203,100,000 +$52,400,000 +35% 31 Dec 2019 10-K 13 Feb 2023 2022 FY
Q3 2019 $186,200,000 +$33,700,000 +22% 30 Sep 2019 10-Q 25 Oct 2019 2019 Q3
Q2 2019 $172,900,000 +$23,300,000 +16% 30 Jun 2019 10-Q 26 Jul 2019 2019 Q2
Q1 2019 $203,100,000 -$26,200,000 -11% 31 Mar 2019 10-K 14 Feb 2020 2019 FY
Q4 2018 $150,700,000 -$74,900,000 -33% 31 Dec 2018 10-K 14 Feb 2022 2021 FY
Q3 2018 $152,500,000 +$10,100,000 +7.1% 30 Sep 2018 10-Q 26 Oct 2018 2018 Q3
Q2 2018 $149,600,000 +$2,500,000 +1.7% 30 Jun 2018 10-Q 27 Jul 2018 2018 Q2
Q1 2018 $229,300,000 +$84,700,000 +59% 31 Mar 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 $225,600,000 -$19,900,000 -8.1% 31 Dec 2017 10-K 12 Feb 2021 2020 FY
Q3 2017 $142,400,000 -$89,000,000 -38% 30 Sep 2017 10-Q 27 Oct 2017 2017 Q3
Q2 2017 $147,100,000 -$78,200,000 -35% 30 Jun 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 $144,600,000 -$77,400,000 -35% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $245,500,000 +$29,400,000 +14% 31 Dec 2016 10-K 14 Feb 2020 2019 FY
Q3 2016 $231,400,000 +$19,000,000 +8.9% 30 Sep 2016 10-Q 28 Oct 2016 2016 Q3
Q2 2016 $225,300,000 +$23,700,000 +12% 30 Jun 2016 10-Q 29 Jul 2016 2016 Q2
Q1 2016 $222,000,000 +$26,200,000 +13% 31 Mar 2016 10-Q 29 Apr 2016 2016 Q1
Q4 2015 $216,100,000 +$23,800,000 +12% 31 Dec 2015 10-K 15 Feb 2019 2018 FY
Q3 2015 $212,400,000 +$31,800,000 +18% 30 Sep 2015 10-Q 29 Oct 2015 2015 Q3
Q2 2015 $201,600,000 +$29,600,000 +17% 30 Jun 2015 10-Q 29 Jul 2015 2015 Q2
Q1 2015 $195,800,000 +$62,600,000 +47% 31 Mar 2015 10-Q 29 Apr 2015 2015 Q1
Q4 2014 $192,300,000 +$64,600,000 +51% 31 Dec 2014 10-K 16 Feb 2018 2017 FY
Q3 2014 $180,600,000 +$52,400,000 +41% 30 Sep 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 $172,000,000 +$46,700,000 +37% 30 Jun 2014 10-Q 04 Aug 2014 2014 Q2
Q1 2014 $133,200,000 +$11,600,000 +9.5% 31 Mar 2014 10-Q 02 May 2014 2014 Q1
Q4 2013 $127,700,000 +$14,100,000 +12% 31 Dec 2013 10-K 17 Feb 2017 2016 FY
Q3 2013 $128,200,000 +$33,300,000 +35% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $125,300,000 +$38,800,000 +45% 30 Jun 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 $121,600,000 +$37,400,000 +44% 31 Mar 2013 10-Q 06 May 2013 2013 Q1
Q4 2012 $113,600,000 +$35,600,000 +46% 31 Dec 2012 10-K 19 Feb 2016 2015 FY
Q3 2012 $94,900,000 +$22,700,000 +31% 30 Sep 2012 10-Q 07 Nov 2012 2012 Q3
Q2 2012 $86,500,000 +$20,300,000 +31% 30 Jun 2012 10-Q 07 Aug 2012 2012 Q2
Q1 2012 $84,200,000 +$24,600,000 +41% 31 Mar 2012 10-Q 09 May 2012 2012 Q1
Q4 2011 $78,000,000 +$22,900,000 +42% 31 Dec 2011 10-K 20 Feb 2015 2014 FY
Q3 2011 $72,200,000 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 $66,200,000 30 Jun 2011 10-Q 08 Aug 2011 2011 Q2
Q1 2011 $59,600,000 31 Mar 2011 10-Q 09 May 2011 2011 Q1
Q4 2010 $55,100,000 31 Dec 2010 10-K 28 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.